M42 Saudi Arabia launches to deepen its long-standing partnership

M42 has officially planted its flag in Saudi Arabia, unveiling M42 Saudi Arabia at the Global Health Exhibition in Riyadh. This isn't a new face on the block — it's a 12-year relationship coming of age. The move aligns neatly with the Kingdom's Vision 2030 plan to build a data-driven, tech-empowered healthcare future. M42, already a name synonymous with AI, genomics, and precision health, is tightening its partnership with the Saudi Ministry of Health — and it's doing so with purpose.

"The incorporation of M42 Saudi Arabia is a natural step for us in building a globally scaled health intelligence ecosystem," said Dimitris Moulavasilis, Group CEO at M42.

How does it work?

At the core, M42 Saudi Arabia will build on Diaverum's network of 40 renal care clinics spread across 33 cities — from Riyadh and Jeddah to Makkah and Madinah. But this isn't just about dialysis anymore. The company is widening its lens:

• Expanding into multi-omics and population health initiatives
• Exploring AI-powered digital health integration
• Developing programs for metabolic and lifestyle diseases
• Supporting Saudi-led research and clinical trials

The company is also doubling down on empowering Saudi talent, equipping the next generation of healthcare professionals with cutting-edge technology and innovation tools. In short, M42 isn't just delivering healthcare; it's helping redesign how healthcare operates.

Why does it matter?

Saudi Arabia's healthcare sector is in the midst of a major transformation — moving from reactive treatment to preventive, predictive, and precision care. M42's arrival reinforces that momentum. The company's data-driven, AI-powered approach is tailor-made for Vision 2030's goals of sustainability and tech integration.

"We're here to partner, invest and help build local capabilities that will define the next chapter of Saudi Arabia's health transformation," said Ziyad Kabli, COO for the Middle East and Asia.

For Saudi citizens, this means earlier diagnosis, smarter disease management, and a health system that learns as it heals. For the region, it's a clear sign that Saudi Arabia is positioning itself as a health innovation hub — not just for the Middle East, but globally.

The context

This expansion is part of a broader regional play. M42 has been busy: it recently launched Jordan's first virtual hospital — the Digital Health Centre — connecting five remote hospitals through a single digital command hub. In Bahrain, it's teaming up with Mumtalakat through Amana Healthcare to deliver long-term and post-acute rehabilitation care in Al Jasra.

In that light, M42 Saudi Arabia isn't an isolated move. It's a cornerstone in a regional ecosystem built around precision medicine, AI-powered analytics, and human-centric care. With its deep Saudi roots through Diaverum and its track record across the Middle East, M42's new venture feels less like an expansion and more like an evolution — one where health, data, and humanity converge in pursuit of a shared vision for the future.